AMA CXO Todd Unger reviews COVID-19 case trends coming out of the long weekend with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering Paxlovid treatments and «rebound infections,» monkeypox infections, and the AMA’s statement on the Texas elementary shootings that have devastated our nation.
Read MoreAMA CXO Todd Unger reviews the latest on vaccines for children ages 6 months through 4 years, as well as boosters for 5-11 year olds with AMA Director of Science, Medicine and Public Health, Andrea Garcia, JD, MPH. Also covering CDC’s recommendation on a second booster shot for people 50 or older, and the latest on the monkeypox outbreak.
Read MoreAMA CXO Todd Unger discusses what physicians and patients need to know about Paxlovid with John Farley, MD, MPH, director of the Office of Infectious Diseases in the Center for Drug Evaluation and Research’s Office of New Drugs at the FDA.
For more information on Paxlovid from the FDA, visit: https://www.fda.gov/drugs/news-events-human-drugs/fda-updates-paxlovid-health-care-providers
Read MoreAMA CXO Todd Unger discusses the status of Covid vaccines for kids under 5 with Paul Offit, MD, director of the Vaccine Education Center and an attending physician in the Division of Infectious Diseases at Children’s Hospital of Philadelphia. Dr. Offit is also a member of the FDA’s vaccine advisory committee.
Read MoreAMA CXO Todd Unger chats with AMA’s immediate past president, Susan Bailey, MD, about big takeaways from her recent conversation with Peter Marks, MD, PhD, director of the Center for Biologics Evaluation and Research at the FDA. Their talk covered COVID-19 second dose boosters and pediatric vaccines.
Read MoreAMA CXO Todd Unger discusses the latest Johnson & Johnson COVID vaccine news with AMA Director of Science, Medicine and Public Health, Andrea Garcia. Also covering a newly released estimate for COVID-19 related deaths using excess mortality, as well as summer spikes of coronavirus cases, hospitalizations, and that masking up in airports or high-risk settings continues to reduce chances of COVID infection.
Read MoreAMA CXO Todd Unger reviews the latest timeline on Moderna and Pfizer vaccine authorizations for young children with AMA Director of Science, Medicine and Public Health, Andrea Garcia. Also covering the rise in COVID cases, FDA’s proposed timing to review data on Novavax and variant-specific vaccines, as well as how to spot fake COVID-19 at-home tests.
Read MoreHow will our nation—and America’s physicians—move beyond this pandemic? Tune in to hear expert physician perspectives on what lies ahead—and to learn how to prepare yourself, your practice and your patients for what’s next. Our physician guests include: Georges Benjamin, MD, Executive director, American Public Health Association; Céline Gounder, MD, Senior fellow and editor-at-large for Public Health, Kaiser Family Foundation and Kaiser Health News; clinical associate professor, Medicine and Infectious Diseases, New York University; Stephen Parodi, MD, executive vice president, External Affairs, Communications, and Brand, The Permanente Federation; associate executive director, The Permanente Medical Group
Read MoreAMA CXO Todd Unger reviews COVID-19 case numbers and the legal battle over mask mandates with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the CDC’s latest health alert for COVID therapies, as well as the FDA’s approval of Remdesivir to treat pediatric coronavirus patients (kids 12 and younger).
More information on the CDC’s health alert: https://emergency.cdc.gov/han/2022/han00463.asp
Read MoreAMA CXO Todd Unger reviews changes to the national mask mandate with AMA Director of Science, Medicine and Public Health Andrea Garcia, including which airlines no longer require masks and the cities still enforcing mask mandates on public transit. Also covering the emerging subvariants BA.2.12 and BA.2.12.1, a new COVID breath test, and why Americans over 60 should get a second booster shot.
Read More